Invasion and metastasis largely determine the clinical course of cancer. A better understanding of the mechanisms required for metastases formation in secondary sites will lead to the development of new and more successful treatment strategies. The present work describes our results with a murine Lewis lung carcinoma model which consists of two cell lines, H-59 and M-27, with different patterns of metastasis in vivo. Using this model, a positive correlation was found between the expression of insulin-like growth factor I receptor (IGF-IR) and the ability of the tumor cells to metastasize to the liver. The highly invasive, highly metastatic, liver colonizing cell line H-59 expressed significantly higher levels (5-fold) of IGF-IR than the poo...
Brain metastasis is a common cause of mortality in cancer patients. Approximately 20-30% of breast c...
NVP-AEW541, a specific ATP-competitive inhibitor of the insulin-like growth factor-1 receptor (IGF1R...
NVP-AEW541, a specific ATP-competitive inhibitor of the insulin-like growth factor-1 receptor (IGF1R...
Intrahepatic and extrahepatic metastases are common findings in hepatocellular carcinoma (HCC). Insu...
AbstractIntrahepatic and extrahepatic metastases are common findings in hepatocellular carcinoma (HC...
AbstractIntrahepatic and extrahepatic metastases are common findings in hepatocellular carcinoma (HC...
Insulin receptor (IR) and the type I IGF receptor (IGF1R) are structurally and functionally related....
Liver metastases are a frequent and often fatal occurrence in cancer patients. A better understandi...
AbstractDespite the type I insulin-like growth factor receptor (IGF-IR) being highly expressed in mo...
Despite the type I insulin-like growth factor receptor (IGF-IR) being highly expressed in more than ...
Cancer metastasis is the major cause of death from malignant disease. The biological factors that di...
AbstractDespite the type I insulin-like growth factor receptor (IGF-IR) being highly expressed in mo...
NVP-AEW541, a specific inhibitor of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kina...
AbstractThe insulin-like growth factor (IGF) pathway is involved in the normal control of fetal deve...
Clinical cancer treatment has focused on the use of cytotoxic agents and/or radiation therapy that t...
Brain metastasis is a common cause of mortality in cancer patients. Approximately 20-30% of breast c...
NVP-AEW541, a specific ATP-competitive inhibitor of the insulin-like growth factor-1 receptor (IGF1R...
NVP-AEW541, a specific ATP-competitive inhibitor of the insulin-like growth factor-1 receptor (IGF1R...
Intrahepatic and extrahepatic metastases are common findings in hepatocellular carcinoma (HCC). Insu...
AbstractIntrahepatic and extrahepatic metastases are common findings in hepatocellular carcinoma (HC...
AbstractIntrahepatic and extrahepatic metastases are common findings in hepatocellular carcinoma (HC...
Insulin receptor (IR) and the type I IGF receptor (IGF1R) are structurally and functionally related....
Liver metastases are a frequent and often fatal occurrence in cancer patients. A better understandi...
AbstractDespite the type I insulin-like growth factor receptor (IGF-IR) being highly expressed in mo...
Despite the type I insulin-like growth factor receptor (IGF-IR) being highly expressed in more than ...
Cancer metastasis is the major cause of death from malignant disease. The biological factors that di...
AbstractDespite the type I insulin-like growth factor receptor (IGF-IR) being highly expressed in mo...
NVP-AEW541, a specific inhibitor of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kina...
AbstractThe insulin-like growth factor (IGF) pathway is involved in the normal control of fetal deve...
Clinical cancer treatment has focused on the use of cytotoxic agents and/or radiation therapy that t...
Brain metastasis is a common cause of mortality in cancer patients. Approximately 20-30% of breast c...
NVP-AEW541, a specific ATP-competitive inhibitor of the insulin-like growth factor-1 receptor (IGF1R...
NVP-AEW541, a specific ATP-competitive inhibitor of the insulin-like growth factor-1 receptor (IGF1R...